Black November Sale!

Get 20% OFF your favorite products with Promo Code:

BlkNov05

Home  /  Blog  /  Current Article

DOCUMENTATION & QUALITY

1P-LSD Detection in Urine and Serum: LC-MS/MS Analysis, Stability and Forensic Research

Understanding how laboratories identify new psychoactive substances requires more than a basic chemical screening. Researchers must also consider biological sample stability, analytical sensitivity and the possibility that a compound may transform before laboratory analysis.

Research into 1-propionyl-LSD (1P-LSD) highlights these challenges. In particular, published studies have examined its detection in urine and serum, its stability under different storage conditions and its potential relationship with LSD. Together, these findings provide important context for forensic toxicology and analytical research.

Introduction to 1P-LSD Detection in Biological Samples

1P-LSD belongs to the lysergamide group of compounds and has a chemical structure closely related to lysergic acid diethylamide (LSD). Its structural relationship with LSD creates an important question for analytical toxicology: can laboratories distinguish the original compound from LSD and identify possible changes that occur in biological samples?

Grumann and colleagues addressed this question in a 2019 study published in the Journal of Pharmaceutical and Biomedical Analysis. Their research focused on validating an LC-MS/MS method for the quantitative analysis of 1P-LSD and LSD in fortified urine and serum samples. The researchers also investigated the stability of 1P-LSD under different storage conditions.

These findings have practical scientific significance. A laboratory result may reflect both the substance originally present and chemical changes that occur before analysis. Therefore, forensic interpretation must consider the complete analytical context rather than relying on a single detected compound.

Central research question: How can laboratories interpret 1P-LSD and LSD findings when biological sample stability and possible conversion may influence the final analytical result?

What Is 1P-LSD? Chemical and Analytical Background

Structural Relationship Between 1P-LSD and LSD

1P-LSD stands for 1-propionyl-lysergic acid diethylamide. It belongs to a broader family of lysergamides that share a related ergoline-based chemical framework.

The main structural distinction involves a propionyl substitution at the N1 position. LSD does not contain this same substituent. Although the compounds share important structural features, laboratories must treat them as distinct analytical targets.

Brandt and colleagues explored this distinction in their 2016 publication, Return of the Lysergamides, Part I. Their work examined the analytical and behavioural characteristics of 1P-LSD and compared its chemical identification with established LSD reference data.

Why Structural Differences Matter in Toxicology

Closely related compounds can create challenges during forensic identification. A laboratory must establish whether its findings support the presence of the original compound, a related substance or a potential transformation product.

For this reason, researchers rely on validated analytical evidence and appropriate reference information. A result that identifies LSD does not automatically establish whether the original exposure involved LSD or a related lysergamide.

Why Sensitive 1P-LSD Detection Methods Are Needed

Challenges in Biological Sample Analysis

Biological samples contain many naturally occurring substances. These components can interfere with analytical measurements, especially when researchers investigate compounds at very low concentrations.

Consequently, a reliable method must demonstrate suitable sensitivity, selectivity and quantitative performance. It should also account for differences between sample matrices, such as urine and serum.

Another important consideration involves the distinction between detection and quantification. Detection indicates that an analytical signal meets the method's identification criteria. Quantification requires additional evidence that supports a concentration measurement within the validated analytical range.

Role of Forensic Toxicology

Forensic toxicology examines chemical substances and their relevance to biological evidence. In investigations involving emerging psychoactive substances, analysts may need to identify compounds that have limited historical reference data.

Therefore, researchers must evaluate analytical findings alongside sample information, case circumstances and the limitations of the available method. This approach reduces the risk of drawing conclusions that the laboratory evidence cannot support.

LC-MS/MS Method Validation for 1P-LSD and LSD

Purpose of the Validated Analytical Method

The 2019 Grumann study developed and validated an LC-MS/MS method for measuring 1P-LSD and LSD in fortified urine and serum samples. The researchers designed the method in response to a forensic intoxication case that required sensitive analytical investigation.

Liquid chromatography separates chemical components within a sample. Tandem mass spectrometry then supports their identification and measurement through compound-specific analytical signals.

Importantly, the study evaluated both compounds. This allowed the researchers to examine the relationship between the original analytical target and LSD as a possible transformation product.

Analytical Performance and Validation Findings

The published study reported accurate and precise measurements, together with good linearity across its calibration range. These characteristics supported the method's quantitative application to the investigated biological matrices.

Calibration range 0.015–0.4 ng/mL
Limit of detection (LOD) 0.005 ng/mL
Lower limit of quantification (LLOQ) 0.015 ng/mL
Biological matrices Fortified urine and serum

These figures describe the analytical performance reported in the specific publication. They should not be interpreted as universal detection limits for every laboratory, instrument or biological sample.

Why Measuring Both Compounds Matters

Measuring 1P-LSD and LSD together provides a more complete analytical picture than measuring either compound alone. For example, a sample may contain LSD even when the original 1P-LSD target remains undetected.

However, analysts must interpret this pattern carefully. The presence of LSD alone cannot establish the exact source of the compound without additional supporting evidence.

1P-LSD Stability in Urine and Serum

Findings From the Published Stability Study

Sample stability formed an important part of the 2019 investigation. The researchers examined fortified urine and serum samples under different storage conditions and evaluated the presence of 1P-LSD and LSD.

The study reported no major degradation of 1P-LSD in the tested samples stored at −20°C, 5°C or room temperature for up to five days. However, the researchers also observed LSD formation in samples kept at room temperature.

This distinction matters because the disappearance of a parent compound and the appearance of a related compound do not necessarily represent the same analytical event.

Temperature-Related Hydrolysis

The researchers associated the observed LSD formation with temperature-dependent hydrolysis of 1P-LSD. The effect reached up to 21% in serum under the reported experimental conditions.

Serum samples showed particular susceptibility to this change. The authors suggested that enzymatically catalysed reactions could contribute to the observed conversion.

The study also reported that sodium fluoride prevented the enzymatic formation of LSD in the investigated serum samples. This finding highlights the importance of matrix-related effects when researchers evaluate biological sample stability.

Implications for Interpreting Laboratory Results

Sample stability can influence how analysts interpret a toxicological result. A laboratory must consider whether a detected compound existed in the sample at collection or appeared through a transformation before analysis.

Nevertheless, fortified-sample experiments do not reproduce every biological process inside a human body. Researchers must distinguish changes observed during sample storage from metabolic changes that occur in vivo.

Research distinction: The 2019 study demonstrated temperature-associated LSD formation in fortified samples. It did not, by itself, establish the complete metabolic pathway inside humans.

1P-LSD Metabolism and Its Relationship With LSD

Evidence From Preclinical Research

Research by Halberstadt and colleagues examined the pharmacological and biotransformation characteristics of several N1-acyl-substituted LSD derivatives, including 1P-LSD and 1B-LSD.

The study explored whether these compounds could undergo transformation into LSD and investigated their pharmacological properties. Its findings supported the possibility of metabolic conversion in animal research models.

However, animal findings cannot automatically establish the same metabolic behaviour in humans. Differences between biological systems require careful interpretation and further evidence.

Evidence From Human Pharmacokinetic Research

Grumann and colleagues published a separate human pharmacokinetic study in 2020. The investigation included two human volunteers and examined analytical findings alongside selected subjective-effect assessments.

The researchers reported that oral administration of 1P-LSD led to the detection of LSD in serum and urine. Their observations supported the possibility that 1P-LSD can undergo rapid conversion to LSD in humans.

The study also reported pharmacokinetic measurements for LSD following the investigated sessions. However, the very small participant group limits how broadly researchers can apply these findings to the wider population.

What the Evidence Does and Does Not Establish

The available publications provide different types of evidence. The 2019 study examined analytical validation and sample stability, while the 2020 investigation provided preliminary human pharmacokinetic observations.

These studies complement one another, but they answer different research questions. Fortified-sample stability results cannot independently prove human metabolism. Likewise, observations from two volunteers cannot establish every possible metabolic pattern.

Therefore, the strongest interpretation considers both publications while clearly acknowledging their individual limitations.

What Did the Published 1P-LSD Intoxication Case Reveal?

Analytical Findings in the Reported Case

The 2019 publication also described a forensic intoxication case involving suspected 1P-LSD exposure. The analytical investigation detected LSD in the available biological samples, while 1P-LSD remained undetected.

The reported concentrations were 0.51 ng/mL LSD in urine and 3.4 ng/mL LSD in serum. The researchers considered these findings alongside their stability experiments and the possibility of rapid conversion.

This case demonstrates why toxicological interpretation requires more than a simple positive-or-negative result. Analysts must consider the identity of detected compounds and the possible reasons behind an absent parent compound.

Forensic Interpretation and Limitations

The absence of detectable 1P-LSD does not automatically rule out earlier exposure. However, the detection of LSD alone also cannot prove that 1P-LSD was the original substance.

Sample timing, analytical sensitivity, matrix effects and supporting case information all influence the interpretation. Consequently, forensic conclusions should remain within the limits of the available evidence.

Related Lysergamide Research and Its Relevance

Analytical Characterization of 1P-LSD

Brandt and colleagues' 2016 paper, Return of the Lysergamides, Part I, provides important background for understanding the analytical identity of 1P-LSD.

The publication examined chromatographic and spectroscopic characterization, including infrared and nuclear magnetic resonance techniques. It also investigated behavioural responses in mice associated with serotonin 5-HT2A receptor activity.

These findings provide historical and analytical context. However, the study does not replace the later LC-MS/MS validation research focused on biological samples.

Research on Other Related Lysergamides

Additional publications have examined related compounds such as AL-LAD, LSZ, ETH-LAD, 1P-ETH-LAD, LSM-775 and 1B-LSD.

These studies contribute to the broader understanding of lysergamide chemistry, analytical identification and pharmacological research. Nevertheless, each compound has its own structural and research profile.

As a result, findings from another lysergamide should not be presented as direct evidence about 1P-LSD unless the relevant study specifically supports that conclusion.

Analytical Research Methods in Related Toxicology Studies

LC-MS/MS and High-Resolution Mass Spectrometry

LC-MS/MS plays a central role in the quantitative method described by Grumann and colleagues. It supports the measurement of selected analytical targets in biological matrices.

High-resolution mass spectrometry serves a broader role in toxicological research. It can support non-targeted screening and the investigation of compounds or metabolites that may not appear in a conventional targeted panel.

Although these techniques share analytical principles, researchers should not treat every published method as interchangeable. Each method requires validation for its intended purpose and sample type.

Biological Models in New Psychoactive Substance Research

Wagmann and colleagues published a 2020 study comparing pooled human liver S9, HepaRG cells and zebrafish larvae for research into new psychoactive substance metabolism. Their investigation included 1P-LSD among several different substance classes.

The study compared the metabolic information produced by these research models. It reported differences in the number and patterns of metabolites identified across the models, highlighting the importance of model selection in toxicological research.

This publication provides useful methodological context. However, it does not serve as a direct replacement for the dedicated 1P-LSD human pharmacokinetic study or the 2019 urine and serum stability investigation.

Limitations and Open Questions in 1P-LSD Research

Although the published research provides valuable findings, several questions remain open. The available evidence does not support every possible conclusion about 1P-LSD metabolism, biological stability or forensic detection.

  • Limited human evidence: The 2020 pharmacokinetic investigation included only two volunteers, which restricts broader conclusions.
  • Sample stability: Fortified-sample experiments cannot fully reproduce every condition found in biological systems.
  • Analytical interpretation: Detecting LSD without 1P-LSD does not independently identify the original exposure.
  • Related compounds: Research on other lysergamides cannot automatically establish identical properties for 1P-LSD.
  • Forensic context: Individual case findings require careful interpretation and should not become universal assumptions.

Future research can help address these limitations through additional validated analytical investigations and a broader evidence base. Until then, researchers and forensic professionals should distinguish established findings from preliminary interpretations.

Frequently Asked Questions About 1P-LSD Detection

Can 1P-LSD be detected in urine?

Yes. The 2019 Grumann study validated an LC-MS/MS method for quantifying 1P-LSD in fortified urine samples. However, detection in an individual case depends on the available sample, analytical method and relevant circumstances.

Can laboratories distinguish 1P-LSD from LSD?

Validated analytical methods can investigate both compounds as separate targets. The 2019 study demonstrated quantitative analysis of 1P-LSD and LSD in fortified urine and serum samples.

Why might a sample show LSD but not 1P-LSD?

Possible explanations include conversion of 1P-LSD into LSD and differences in analytical detectability. The 2019 case report described LSD detection without detectable 1P-LSD, while later human research provided additional evidence of possible conversion.

What is the role of LC-MS/MS in 1P-LSD analysis?

LC-MS/MS supports the separation, identification and quantitative measurement of selected compounds. Researchers used this technique in the published validation study involving fortified urine and serum samples.

Does sample stability affect forensic interpretation?

Yes. The 2019 research observed temperature-associated formation of LSD in fortified samples. Therefore, stability findings can influence how analysts interpret the relationship between the original compound and the final laboratory result.

What did the human pharmacokinetic study establish?

The 2020 study involving two volunteers reported LSD in serum and urine following the investigated 1P-LSD sessions. The findings supported possible conversion in humans, although the small participant group limits generalization.

Are findings from other lysergamides directly applicable to 1P-LSD?

No. Related studies can provide useful scientific context, but differences in chemical structure and research design mean that each compound requires its own supporting evidence.

LATEST RESEARCH

Explore the latest articles

15 articles
FIND AN ARTICLE

Search the library

Novel LSD Analogs in Blood vs Dried Blood Spots: A 365-Day Stability Study
PEPTIDE Nov 13, 2026

Novel LSD Analogs in Blood vs Dried Blood Spots: A 365-Day Stability Study

Forensic laboratories need reliable biological samples to identify emerging psychoactive substances. However, the chemical stability of a compound...

Read article →
ALD-52 and 1P-LSD Stability: GC-MS Analysis, Degradation and Forensic Research
PEPTIDE Nov 13, 2026

ALD-52 and 1P-LSD Stability: GC-MS Analysis, Degradation and Forensic Research

Understanding the stability of emerging psychoactive substances is an important part of modern forensic chemistry. In particular, researchers...

Read article →
1P-LSD Detection in Urine and Serum: LC-MS/MS Analysis, Stability and Forensic Research
PEPTIDE Nov 11, 2026

1P-LSD Detection in Urine and Serum: LC-MS/MS Analysis, Stability and Forensic Research

Understanding how laboratories identify new psychoactive substances requires more than a basic chemical screening. Researchers must also consider...

Read article →
1P-LSD: Analytical Characterization, Chemical Identification and Scientific Research
PEPTIDE Nov 9, 2026

1P-LSD: Analytical Characterization, Chemical Identification and Scientific Research

1P-LSD, also known as 1-propionyl-d-lysergic acid diethylamide, is a lysergamide derivative that has attracted scientific interest because of...

Read article →
GLP-1 Research Compounds: Tirzepatide vs Retatrutide – Mechanisms, Receptors and Key Differences
PEPTIDE Nov 9, 2026

GLP-1 Research Compounds: Tirzepatide vs Retatrutide – Mechanisms, Receptors and Key Differences

GLP-1 research compounds have become an important subject in metabolic and peptide research. Tirzepatide and Retatrutide are two...

Read article →
Semaglutide vs Tirzepatide: A Complete Research Comparison
PEPTIDE Oct 8, 2026

Semaglutide vs Tirzepatide: A Complete Research Comparison

Read article →
What Is GHK-Cu? Complete Guide to Copper Peptide Chemistry, Research & Purity
PEPTIDE Oct 8, 2026

What Is GHK-Cu? Complete Guide to Copper Peptide Chemistry, Research & Purity

Read article →
Tirzepatide Laboratory Research Peptide 20mg | Lyophilized Powder
UNCATEGORIZED Sep 3, 2026

Tirzepatide Laboratory Research Peptide 20mg | Lyophilized Powder

Tirzepatide Laboratory Research Peptide 20mg Scientific overview of tirzepatide, its molecular characteristics, receptor activity, lyophilized research material, and...

Read article →
Retatrutide 60mg Research Peptide: Scientific Overview
UNCATEGORIZED Sep 2, 2026

Retatrutide 60mg Research Peptide: Scientific Overview

Laboratory Research • Peptide Science Retatrutide 60mg Research Peptide: Scientific Overview An educational overview of retatrutide, its research...

Read article →
What Is 5-Amino-1MQ? Research Overview
UNCATEGORIZED Aug 30, 2026

What Is 5-Amino-1MQ? Research Overview

What Is 5-Amino-1MQ? Explore the identity, research background, and scientific significance of 5-Amino-1MQ in laboratory research. Research Purpose:...

Read article →
5-Amino-1MQ 50mg: NNMT Research Explained
UNCATEGORIZED Aug 11, 2026

5-Amino-1MQ 50mg: NNMT Research Explained

5-Amino-1MQ 50mg: An Educational Research Overview Understanding NNMT inhibition, research terminology, and the current evidence. Compound 5-Amino-1MQ Research...

Read article →
KLOW Peptide Blend 80mg: Complete Research Guide
UNCATEGORIZED Aug 11, 2026

KLOW Peptide Blend 80mg: Complete Research Guide

KLOW Peptide Blend 80mg: An Educational Overview Understanding peptide blends, research terminology, product labeling, and evidence. Category Peptide...

Read article →
TB-500 10mg Research Peptide: Complete Educational Guide
UNCATEGORIZED Aug 11, 2026

TB-500 10mg Research Peptide: Complete Educational Guide

TB-500 10mg Research Peptide: An Educational Overview A neutral introduction to TB-500, its research classification, terminology, and important...

Read article →
Multi-Peptide Laboratory Research & Molecular Science
PEPTIDE Aug 3, 2026

Multi-Peptide Laboratory Research & Molecular Science

Laboratory Research Article Cellular Research, Peptide Science & Laboratory Characteristics Discover how multi-peptide formulations are investigated in modern...

Read article →
Mechanism of Action, ERR Biology and Metabolic Research
PEPTIDE Jul 31, 2026

Mechanism of Action, ERR Biology and Metabolic Research

Scientific Research Compound Explore the science behind SLU-PP-332. It is a synthetic pan-estrogen-related receptor agonist investigated for mitochondrial...

Read article →